Cholera toxin chimera and its use as a staph vaccine
AssigneeBoise State University
InventorJuliette Tinker
Life of this patent
Estimating the term…
Abstract
The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
Claims12
A chimeric protein comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:
- 2 or an amino acid sequence that is at least 90% identical to SEQ ID NO:
- 3 and a truncated iron-regulated surface determinant A (IsdA) protein of S. aureus of SEQ ID NO:
- 4 as present within the amino acid sequence of SEQ ID NO:
- 5 or SEQ ID NO:
- 6.
Dependencies are inferred from the claim text.